Novavax Aims to Deploy Covid-19 Vaccine by December: R&D Head

The transcript discusses the development and deployment of vaccines, focusing on efficacy trials, FDA reviews, and global distribution strategies. It highlights the importance of funding from organizations like the Gates Foundation and Seppi, and the need for infrastructure to quickly respond to future pandemics. The conversation also touches on the potential for profit and the necessity of global cooperation to prevent the return of diseases.

What challenges are mentioned regarding vaccine distribution to less developed nations?

What role does the Gates Foundation play in the vaccine development process?

What implications does the small dose requirement of the vaccine have for global supply?